The global Vinca API market was valued at US$ 133 million in 2025 and is anticipated to reach US$ 215 million by 2032, at a CAGR of 7.2% from 2026 to 2032.

Vinca API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Vinca API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Vinca alkaloids are a class of plant-derived compounds that are widely used in the treatment of cancer. They are extracted from the Madagascar periwinkle plant (Catharanthus roseus), formerly classified under the Vinca genus, which gives these compounds their name. The four major vinca alkaloids used in clinical settings are vincristine, vinblastine, vinorelbine, and vindesine. These alkaloids function as mitotic inhibitors, which means they interfere with cell division, making them particularly effective in halting the proliferation of rapidly dividing cancer cells.

Vinca alkaloids exert their anticancer effects by binding to tubulin, a structural protein essential for microtubule formation during cell division. By disrupting the assembly of microtubules, vinca alkaloids prevent cancer cells from completing mitosis, leading to apoptosis or programmed cell death. This mechanism makes them valuable in chemotherapy regimens for various types of cancers, including leukemias, lymphomas, breast cancer, lung cancer, and testicular cancer.

The market for vinca alkaloid products has grown significantly in recent years due to the increasing prevalence of cancer worldwide. The demand for effective chemotherapy drugs, along with continuous research into new formulations and combinations, has propelled the expansion of this sector. The global vinca alkaloid market encompasses various stakeholders, including pharmaceutical companies, research institutions, hospitals, and healthcare providers.

Vinca alkaloids remain a cornerstone of chemotherapy despite the emergence of new cancer treatments. Their ability to target rapidly dividing cells makes them invaluable in treating a range of malignancies, from leukemia to lung cancer. While challenges such as side effects, supply chain issues, and competition from novel therapies persist, the market continues to evolve with new developments in drug formulation, combination strategies, and precision oncology.

The global demand for vinca alkaloid products is expected to remain strong, particularly in emerging markets where access to chemotherapy is expanding. With ongoing research and investment, vinca alkaloids will likely continue to play a critical role in cancer treatment for years to come.

Global key players of Vinca Alkaloid include Minakem, Fine Chemicals Corporation, etc. Global top 3 companies hold a share about 40%. China is the largest market, with a share about 50%, followed by North America and Europe with the share about 15% respectively. In terms of product, Vinorelbine is the largest segment, with a share over 40%. And in terms of application, the largest application is Lymphoma, with a share about 25%.

This report delivers a comprehensive overview of the global Vinca API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vinca API. The Vinca API market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Vinca API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Vinca API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Vinca API Market Report

Report Metric	Details
Report Name	Vinca API Market
Accounted market size in 2025	US$ 133 million
Forecasted market size in 2032	US$ 215 million
CAGR	7.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Vinblastine Vincristine Vindesine Vinorelbine
by Application	Lymphoma Breast Cancer Lung Cancer Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Minakem, Fine Chemicals Corporation (Aspen), Vinkem, Pierre Fabre, Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological, Guangzhou Person Pharmaceutical, Hubei Honch Pharmaceutical, Hanson Pharma, Hainan Yueyang Biotechnology, Qilu Pharmaceutical, Covex SA, Hainan Periwinkle Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Vinca API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Vinca API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Vinca API Market growing?

Ans: The Vinca API Market witnessing a CAGR of 7.2% during the forecast period 2026-2032.

What is the Vinca API Market size in 2032?

Ans: The Vinca API Market size in 2032 will be US$ 215 million.

What is the market share of major companies in Vinca API Market?

Ans: Global top 3 companies hold a share about 40%.

What is the Vinca API Market share by type?

Ans: In terms of product, Vinorelbine is the largest segment, with a share over 40%.

What is the Vinca API Market share by application?

Ans: And in terms of application, the largest application is Lymphoma, with a share about 25%.

Who are the main players in the Vinca API Market report?

Ans: The main players in the Vinca API Market are Minakem, Fine Chemicals Corporation (Aspen), Vinkem, Pierre Fabre, Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological, Guangzhou Person Pharmaceutical, Hubei Honch Pharmaceutical, Hanson Pharma, Hainan Yueyang Biotechnology, Qilu Pharmaceutical, Covex SA, Hainan Periwinkle Pharmaceutical

What are the Application segmentation covered in the Vinca API Market report?

Ans: The Applications covered in the Vinca API Market report are Lymphoma, Breast Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Vinca API Market report?

Ans: The Types covered in the Vinca API Market report are Vinblastine, Vincristine, Vindesine, Vinorelbine

1 Vinca API Market Overview

1.1 Product Definition

1.2 Vinca API by Type

1.2.1 Global Vinca API Market Value by Type: 2025 vs 2032

1.2.2 Vinblastine

1.2.3 Vincristine

1.2.4 Vindesine

1.2.5 Vinorelbine

1.3 Vinca API by Application

1.3.1 Global Vinca API Market Value by Application: 2025 vs 2032

1.3.2 Lymphoma

1.3.3 Breast Cancer

1.3.4 Lung Cancer

1.3.5 Others

1.4 Global Vinca API Market Size Estimates and Forecasts

1.4.1 Global Vinca API Revenue 2021–2032

1.4.2 Global Vinca API Sales 2021–2032

1.4.3 Global Vinca API Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Vinca API Market Competition by Manufacturers

2.1 Global Vinca API Sales Market Share by Manufacturers (2021–2026)

2.2 Global Vinca API Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Vinca API Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Vinca API, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Vinca API, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Vinca API, Product Types and Applications

2.7 Global Key Manufacturers of Vinca API, Date of Entry into the Industry

2.8 Global Vinca API Market Competitive Situation and Trends

2.8.1 Global Vinca API Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Vinca API Players Market Share by Revenue

2.8.3 Global Vinca API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Vinca API Market Scenario by Region

3.1 Global Vinca API Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Vinca API Sales by Region: 2021–2032

3.2.1 Global Vinca API Sales by Region: 2021–2026

3.2.2 Global Vinca API Sales by Region: 2027–2032

3.3 Global Vinca API Revenue by Region: 2021–2032

3.3.1 Global Vinca API Revenue by Region: 2021–2026

3.3.2 Global Vinca API Revenue by Region: 2027–2032

3.4 North America Vinca API Market Facts & Figures by Country

3.4.1 North America Vinca API Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Vinca API Sales by Country (2021–2032)

3.4.3 North America Vinca API Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Vinca API Market Facts & Figures by Country

3.5.1 Europe Vinca API Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Vinca API Sales by Country (2021–2032)

3.5.3 Europe Vinca API Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Vinca API Market Facts & Figures by Region

3.6.1 Asia Pacific Vinca API Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Vinca API Sales by Region (2021–2032)

3.6.3 Asia Pacific Vinca API Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Vinca API Market Facts & Figures by Country

3.7.1 Latin America Vinca API Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Vinca API Sales by Country (2021–2032)

3.7.3 Latin America Vinca API Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Vinca API Market Facts & Figures by Country

3.8.1 Middle East and Africa Vinca API Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Vinca API Sales by Country (2021–2032)

3.8.3 Middle East and Africa Vinca API Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Vinca API Sales by Type (2021–2032)

4.1.1 Global Vinca API Sales by Type (2021–2026)

4.1.2 Global Vinca API Sales by Type (2027–2032)

4.1.3 Global Vinca API Sales Market Share by Type (2021–2032)

4.2 Global Vinca API Revenue by Type (2021–2032)

4.2.1 Global Vinca API Revenue by Type (2021–2026)

4.2.2 Global Vinca API Revenue by Type (2027–2032)

4.2.3 Global Vinca API Revenue Market Share by Type (2021–2032)

4.3 Global Vinca API Price by Type (2021–2032)

5 Segment by Application

5.1 Global Vinca API Sales by Application (2021–2032)

5.1.1 Global Vinca API Sales by Application (2021–2026)

5.1.2 Global Vinca API Sales by Application (2027–2032)

5.1.3 Global Vinca API Sales Market Share by Application (2021–2032)

5.2 Global Vinca API Revenue by Application (2021–2032)

5.2.1 Global Vinca API Revenue by Application (2021–2026)

5.2.2 Global Vinca API Revenue by Application (2027–2032)

5.2.3 Global Vinca API Revenue Market Share by Application (2021–2032)

5.3 Global Vinca API Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Minakem

6.1.1 Minakem Company Information

6.1.2 Minakem Description and Business Overview

6.1.3 Minakem Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Minakem Vinca API Product Portfolio

6.1.5 Minakem Recent Developments/Updates

6.2 Fine Chemicals Corporation (Aspen)

6.2.1 Fine Chemicals Corporation (Aspen) Company Information

6.2.2 Fine Chemicals Corporation (Aspen) Description and Business Overview

6.2.3 Fine Chemicals Corporation (Aspen) Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Fine Chemicals Corporation (Aspen) Vinca API Product Portfolio

6.2.5 Fine Chemicals Corporation (Aspen) Recent Developments/Updates

6.3 Vinkem

6.3.1 Vinkem Company Information

6.3.2 Vinkem Description and Business Overview

6.3.3 Vinkem Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Vinkem Vinca API Product Portfolio

6.3.5 Vinkem Recent Developments/Updates

6.4 Pierre Fabre

6.4.1 Pierre Fabre Company Information

6.4.2 Pierre Fabre Description and Business Overview

6.4.3 Pierre Fabre Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Pierre Fabre Vinca API Product Portfolio

6.4.5 Pierre Fabre Recent Developments/Updates

6.5 Guangzhou Hanfang Pharmaceutical

6.5.1 Guangzhou Hanfang Pharmaceutical Company Information

6.5.2 Guangzhou Hanfang Pharmaceutical Description and Business Overview

6.5.3 Guangzhou Hanfang Pharmaceutical Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Guangzhou Hanfang Pharmaceutical Vinca API Product Portfolio

6.5.5 Guangzhou Hanfang Pharmaceutical Recent Developments/Updates

6.6 Hainan Vinca Biological

6.6.1 Hainan Vinca Biological Company Information

6.6.2 Hainan Vinca Biological Description and Business Overview

6.6.3 Hainan Vinca Biological Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Hainan Vinca Biological Vinca API Product Portfolio

6.6.5 Hainan Vinca Biological Recent Developments/Updates

6.7 Guangzhou Person Pharmaceutical

6.7.1 Guangzhou Person Pharmaceutical Company Information

6.7.2 Guangzhou Person Pharmaceutical Description and Business Overview

6.7.3 Guangzhou Person Pharmaceutical Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Guangzhou Person Pharmaceutical Vinca API Product Portfolio

6.7.5 Guangzhou Person Pharmaceutical Recent Developments/Updates

6.8 Hubei Honch Pharmaceutical

6.8.1 Hubei Honch Pharmaceutical Company Information

6.8.2 Hubei Honch Pharmaceutical Description and Business Overview

6.8.3 Hubei Honch Pharmaceutical Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Hubei Honch Pharmaceutical Vinca API Product Portfolio

6.8.5 Hubei Honch Pharmaceutical Recent Developments/Updates

6.9 Hanson Pharma

6.9.1 Hanson Pharma Company Information

6.9.2 Hanson Pharma Description and Business Overview

6.9.3 Hanson Pharma Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Hanson Pharma Vinca API Product Portfolio

6.9.5 Hanson Pharma Recent Developments/Updates

6.10 Hainan Yueyang Biotechnology

6.10.1 Hainan Yueyang Biotechnology Company Information

6.10.2 Hainan Yueyang Biotechnology Description and Business Overview

6.10.3 Hainan Yueyang Biotechnology Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Hainan Yueyang Biotechnology Vinca API Product Portfolio

6.10.5 Hainan Yueyang Biotechnology Recent Developments/Updates

6.11 Qilu Pharmaceutical

6.11.1 Qilu Pharmaceutical Company Information

6.11.2 Qilu Pharmaceutical Description and Business Overview

6.11.3 Qilu Pharmaceutical Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Qilu Pharmaceutical Vinca API Product Portfolio

6.11.5 Qilu Pharmaceutical Recent Developments/Updates

6.12 Covex SA

6.12.1 Covex SA Company Information

6.12.2 Covex SA Description and Business Overview

6.12.3 Covex SA Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Covex SA Vinca API Product Portfolio

6.12.5 Covex SA Recent Developments/Updates

6.13 Hainan Periwinkle Pharmaceutical

6.13.1 Hainan Periwinkle Pharmaceutical Company Information

6.13.2 Hainan Periwinkle Pharmaceutical Description and Business Overview

6.13.3 Hainan Periwinkle Pharmaceutical Vinca API Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Hainan Periwinkle Pharmaceutical Vinca API Product Portfolio

6.13.5 Hainan Periwinkle Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Vinca API Industry Chain Analysis

7.2 Vinca API Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Vinca API Production Mode & Process Analysis

7.4 Vinca API Sales and Marketing

7.4.1 Vinca API Sales Channels

7.4.2 Vinca API Distributors

7.5 Vinca API Customer Analysis

8 Vinca API Market Dynamics

8.1 Vinca API Industry Trends

8.2 Vinca API Market Drivers

8.3 Vinca API Market Challenges

8.4 Vinca API Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Minakem

COVEX SA

Hainan Periwinkle Pharmaceutical

Vinkem

Pierre Fabre

Guangzhou Hanfang Pharmaceutical

Hainan Vinca Biological

Guangzhou Person Pharmaceutical

Hubei Honch Pharmaceutical

Hanson Pharma

Hainan Yueyang Biotechnology

Qilu Pharmaceutical

Fine Chemicals Corporation (Aspen)

List of Tables

Table 1. Global Vinca API Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Vinca API Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Vinca API Market Competitive Situation by Manufacturers in 2025

Table 4. Global Vinca API Sales (Kg) of Key Manufacturers (2021–2026)

Table 5. Global Vinca API Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Vinca API Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Vinca API Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Vinca API Average Price (US$/g) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Vinca API, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Vinca API, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Vinca API, Product Types and Applications

Table 12. Global Key Manufacturers of Vinca API, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Vinca API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vinca API Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Vinca API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Vinca API Sales by Region (Kg), 2021–2026

Table 18. Global Vinca API Sales Market Share by Region (2021–2026)

Table 19. Global Vinca API Sales by Region (Kg), 2027–2032

Table 20. Global Vinca API Sales Market Share by Region (2027–2032)

Table 21. Global Vinca API Revenue by Region (US$ Million), 2021–2026

Table 22. Global Vinca API Revenue Market Share by Region (2021–2026)

Table 23. Global Vinca API Revenue by Region (US$ Million), 2027–2032

Table 24. Global Vinca API Revenue Market Share by Region (2027–2032)

Table 25. North America Vinca API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Vinca API Sales by Country (Kg), 2021–2026

Table 27. North America Vinca API Sales by Country (Kg), 2027–2032

Table 28. North America Vinca API Revenue by Country (US$ Million), 2021–2026

Table 29. North America Vinca API Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Vinca API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Vinca API Sales by Country (Kg), 2021–2026

Table 32. Europe Vinca API Sales by Country (Kg), 2027–2032

Table 33. Europe Vinca API Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Vinca API Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Vinca API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Vinca API Sales by Region (Kg), 2021–2026

Table 37. Asia Pacific Vinca API Sales by Region (Kg), 2027–2032

Table 38. Asia Pacific Vinca API Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Vinca API Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Vinca API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Vinca API Sales by Country (Kg), 2021–2026

Table 42. Latin America Vinca API Sales by Country (Kg), 2027–2032

Table 43. Latin America Vinca API Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Vinca API Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Vinca API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Vinca API Sales by Country (Kg), 2021–2026

Table 47. Middle East and Africa Vinca API Sales by Country (Kg), 2027–2032

Table 48. Middle East and Africa Vinca API Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Vinca API Revenue by Country (US$ Million), 2027–2032

Table 50. Global Vinca API Sales (Kg) by Type (2021–2026)

Table 51. Global Vinca API Sales (Kg) by Type (2027–2032)

Table 52. Global Vinca API Sales Market Share by Type (2021–2026)

Table 53. Global Vinca API Sales Market Share by Type (2027–2032)

Table 54. Global Vinca API Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Vinca API Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Vinca API Revenue Market Share by Type (2021–2026)

Table 57. Global Vinca API Revenue Market Share by Type (2027–2032)

Table 58. Global Vinca API Price (US$/g) by Type (2021–2026)

Table 59. Global Vinca API Price (US$/g) by Type (2027–2032)

Table 60. Global Vinca API Sales (Kg) by Application (2021–2026)

Table 61. Global Vinca API Sales (Kg) by Application (2027–2032)

Table 62. Global Vinca API Sales Market Share by Application (2021–2026)

Table 63. Global Vinca API Sales Market Share by Application (2027–2032)

Table 64. Global Vinca API Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Vinca API Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Vinca API Revenue Market Share by Application (2021–2026)

Table 67. Global Vinca API Revenue Market Share by Application (2027–2032)

Table 68. Global Vinca API Price (US$/g) by Application (2021–2026)

Table 69. Global Vinca API Price (US$/g) by Application (2027–2032)

Table 70. Minakem Company Information

Table 71. Minakem Description and Business Overview

Table 72. Minakem Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 73. Minakem Vinca API Product

Table 74. Minakem Recent Developments/Updates

Table 75. Fine Chemicals Corporation (Aspen) Company Information

Table 76. Fine Chemicals Corporation (Aspen) Description and Business Overview

Table 77. Fine Chemicals Corporation (Aspen) Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 78. Fine Chemicals Corporation (Aspen) Vinca API Product

Table 79. Fine Chemicals Corporation (Aspen) Recent Developments/Updates

Table 80. Vinkem Company Information

Table 81. Vinkem Description and Business Overview

Table 82. Vinkem Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 83. Vinkem Vinca API Product

Table 84. Vinkem Recent Developments/Updates

Table 85. Pierre Fabre Company Information

Table 86. Pierre Fabre Description and Business Overview

Table 87. Pierre Fabre Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 88. Pierre Fabre Vinca API Product

Table 89. Pierre Fabre Recent Developments/Updates

Table 90. Guangzhou Hanfang Pharmaceutical Company Information

Table 91. Guangzhou Hanfang Pharmaceutical Description and Business Overview

Table 92. Guangzhou Hanfang Pharmaceutical Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 93. Guangzhou Hanfang Pharmaceutical Vinca API Product

Table 94. Guangzhou Hanfang Pharmaceutical Recent Developments/Updates

Table 95. Hainan Vinca Biological Company Information

Table 96. Hainan Vinca Biological Description and Business Overview

Table 97. Hainan Vinca Biological Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 98. Hainan Vinca Biological Vinca API Product

Table 99. Hainan Vinca Biological Recent Developments/Updates

Table 100. Guangzhou Person Pharmaceutical Company Information

Table 101. Guangzhou Person Pharmaceutical Description and Business Overview

Table 102. Guangzhou Person Pharmaceutical Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 103. Guangzhou Person Pharmaceutical Vinca API Product

Table 104. Guangzhou Person Pharmaceutical Recent Developments/Updates

Table 105. Hubei Honch Pharmaceutical Company Information

Table 106. Hubei Honch Pharmaceutical Description and Business Overview

Table 107. Hubei Honch Pharmaceutical Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 108. Hubei Honch Pharmaceutical Vinca API Product

Table 109. Hubei Honch Pharmaceutical Recent Developments/Updates

Table 110. Hanson Pharma Company Information

Table 111. Hanson Pharma Description and Business Overview

Table 112. Hanson Pharma Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 113. Hanson Pharma Vinca API Product

Table 114. Hanson Pharma Recent Developments/Updates

Table 115. Hainan Yueyang Biotechnology Company Information

Table 116. Hainan Yueyang Biotechnology Description and Business Overview

Table 117. Hainan Yueyang Biotechnology Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 118. Hainan Yueyang Biotechnology Vinca API Product

Table 119. Hainan Yueyang Biotechnology Recent Developments/Updates

Table 120. Qilu Pharmaceutical Company Information

Table 121. Qilu Pharmaceutical Description and Business Overview

Table 122. Qilu Pharmaceutical Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 123. Qilu Pharmaceutical Vinca API Product

Table 124. Qilu Pharmaceutical Recent Developments/Updates

Table 125. Covex SA Company Information

Table 126. Covex SA Description and Business Overview

Table 127. Covex SA Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 128. Covex SA Vinca API Product

Table 129. Covex SA Recent Developments/Updates

Table 130. Hainan Periwinkle Pharmaceutical Company Information

Table 131. Hainan Periwinkle Pharmaceutical Description and Business Overview

Table 132. Hainan Periwinkle Pharmaceutical Vinca API Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)

Table 133. Hainan Periwinkle Pharmaceutical Vinca API Product

Table 134. Hainan Periwinkle Pharmaceutical Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Vinca API Distributors List

Table 138. Vinca API Customers List

Table 139. Vinca API Market Trends

Table 140. Vinca API Market Drivers

Table 141. Vinca API Market Challenges

Table 142. Vinca API Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Vinca API

Figure 2. Global Vinca API Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Vinca API Market Share by Type: 2025 & 2032

Figure 4. Vinblastine Product Picture

Figure 5. Vincristine Product Picture

Figure 6. Vindesine Product Picture

Figure 7. Vinorelbine Product Picture

Figure 8. Global Vinca API Market Value by Application (US$ Million), 2021–2032

Figure 9. Global Vinca API Market Share by Application: 2025 & 2032

Figure 10. Lymphoma

Figure 11. Breast Cancer

Figure 12. Lung Cancer

Figure 13. Others

Figure 14. Global Vinca API Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Vinca API Market Size (US$ Million), 2021–2032

Figure 16. Global Vinca API Sales (Kg), 2021–2032

Figure 17. Global Vinca API Average Price (US$/g), 2021–2032

Figure 18. Vinca API Report Years Considered

Figure 19. Vinca API Sales Share by Manufacturers in 2025

Figure 20. Global Vinca API Revenue Share by Manufacturers in 2025

Figure 21. Top 5 and Top 10 Global Vinca API Players: Market Share by Revenue in Vinca API in 2025

Figure 22. Vinca API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 23. Global Vinca API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 24. North America Vinca API Sales Market Share by Country (2021–2032)

Figure 25. North America Vinca API Revenue Market Share by Country (2021–2032)

Figure 26. United States Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. Canada Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. Europe Vinca API Sales Market Share by Country (2021–2032)

Figure 29. Europe Vinca API Revenue Market Share by Country (2021–2032)

Figure 30. Germany Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. France Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. U.K. Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Italy Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Russia Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Asia Pacific Vinca API Sales Market Share by Region (2021–2032)

Figure 36. Asia Pacific Vinca API Revenue Market Share by Region (2021–2032)

Figure 37. China Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Japan Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. South Korea Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. India Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Australia Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. China Taiwan Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Southeast Asia Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Latin America Vinca API Sales Market Share by Country (2021–2032)

Figure 45. Latin America Vinca API Revenue Market Share by Country (2021–2032)

Figure 46. Mexico Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Brazil Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Argentina Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Colombia Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Middle East and Africa Vinca API Sales Market Share by Country (2021–2032)

Figure 51. Middle East and Africa Vinca API Revenue Market Share by Country (2021–2032)

Figure 52. Turkey Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Saudi Arabia Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. UAE Vinca API Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Global Sales Market Share of Vinca API by Type (2021–2032)

Figure 56. Global Revenue Market Share of Vinca API by Type (2021–2032)

Figure 57. Global Vinca API Price (US$/g) by Type (2021–2032)

Figure 58. Global Sales Market Share of Vinca API by Application (2021–2032)

Figure 59. Global Revenue Market Share of Vinca API by Application (2021–2032)

Figure 60. Global Vinca API Price (US$/g) by Application (2021–2032)

Figure 61. Vinca API Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Vinca Alkaloid Compounds Market Research Report 2024

Vincristine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vinca Alkaloids Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vindesine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vincamine Market Research Report 2025

Global Vinca Alkaloid Market Research Report 2025

Global Vinburnine Market Research Report 2025

Global Vinca Alkaloid Extract Market Research Report 2025

Global Vinpocetine API Market Research Report 2025

Global Vinpocetine Drug Market Research Report 2025

Vinorelbine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vincristine Market Research Report 2024

Global Vinorelbine Market Research Report 2024

Global Mitotic Inhibitors Market Research Report 2024

Global Dauricine Market Research Report 2024

Global Colchicine API Market Research Report 2024

Global Madagascar Periwinkle Extract Market Research Report 2024

Vinblastine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Jervine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions